Facebook Linkedin RSS Twitter Youtube
Home 2024

Recombinant vaccine

Science Summer Reads: GEN Editors List Their Favorites
Coronavirus

Science Summer Reads: GEN Editors List Their Favorites

Nucleic Acid Manufacturing Needs Digital Innovation
Bioprocessing

Nucleic Acid Manufacturing Needs Digital Innovation

BioNTech Advances Plans for mRNA Vaccine Production in Africa by 2025
Bioprocessing

BioNTech Advances Plans for mRNA Vaccine Production in Africa by 2025

Making Diverse, Non-Lipid Nanocarriers
Bioprocessing

Making Diverse, Non-Lipid Nanocarriers

Next-Generation mRNA Design: Increasing mRNA potency with a New Cap Analog
Drug Discovery

Next-Generation mRNA Design: Increasing mRNA potency with a New Cap Analog

Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools
Drug Discovery

Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools

University of Queensland (UQ), CEPI, CSL Behring and Dynavax – UQ-CSL V451
News

University of Queensland (UQ), CEPI, CSL Behring and Dynavax – UQ-CSL V451

Mitsubishi Tanabe Buys Medicago for $357M
Drug Discovery

Mitsubishi Tanabe Buys Medicago for $357M

ImmuneRegen’s Adjuvant to Be Tested with the Biodesign Institute’s Vaccine against Norwalk Viruses
News

ImmuneRegen’s Adjuvant to Be Tested with the Biodesign Institute’s Vaccine against Norwalk Viruses

DOR Biopharma Awarded $5.3M to Advance Ricin Toxin and Botulinum Toxin Vaccine Programs
News

DOR Biopharma Awarded $5.3M to Advance Ricin Toxin and Botulinum Toxin Vaccine Programs

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.